Skip to the content
Sign In
Account
Activating this button will toggle the display of additional content
Account
Sign out
Slate homepage
Submit search
Enter query
Activating this button will toggle the display of additional content
Light
Dark
Auto
News & Politics
Culture
Technology
Business
Human Interest
Podcasts
Menu
Open menu
Close menu
News & Politics
Culture
Technology
Business
Human Interest
Podcasts
Search
Activating this button will toggle the display of additional content
Light
Dark
Auto
Follow us
Slate on Instagram
Slate on Twitter
Slate on Facebook
Subscribe
Sign in
Account
Sign out
Slate homepage
Account
*
Makes You Go "Huh!"
Follow Us
Slate on Instagram
Slate on Twitter
Slate on Facebook
Advertisement
Advertisement
← Return to Article
Comments on:
Spironolactone, a Standard Drug in Hormone Treatment for Trans Women, Has Controversial Side Effects
But an underresourced, check-box-focused medical system insists on one size fitting all.
Advertisement
Please enable Javascript and cookies to read and post comments.
Advertisement
Spironolactone, a Standard Drug in Hormone Treatment for Trans Women, Has Controversial Side Effects
But an underresourced, check-box-focused medical system insists on one size fitting all.